Morningside Venture Investments Limited 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-16 4:00 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 0 0.000% | -6,634,956 (Position Closed) | Filing |
| 2022-02-14 4:18 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 19,495,148 40.900% | 19,495,148 (New Position) | Filing |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 6,634,956 8.030% | 6,634,956 (New Position) | Filing |